Ireland based, US stock market listed, Icon PLC has been accused of engaging in a “scheme to deceive the market” as a huge US pension fund filed a legal class action against the clinical trials ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the ...

Trans activists and unregulated clinics have sought to pressure GPs into illegally prescribing puberty blockers, the NHS has ...

Whenever a new drug goes into the first stages of clinical trial, there are certain groups of people that are excluded from ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

LVS Advisory, a New York City-based full-service investment firm, recently released its first-quarter 2025 investor letter. A ...

Private computation and storage network Nillion, dubbed the "blind computer," debuted its mainnet and native token NIL on Monday. However, the token's market capitalization has dropped 12% in the ...

Credit: MUNGKHOOD STUDIO/Shutterstock. Clinical research organisation (CRO) ICON has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes ICON the ...

“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations ...

Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...